IDF

The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.

Institute Director

Your Contribution

The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.

Institute Director

Your Contribution

EDENT1FI

EDENT1FI is a global consortium comprised of 28 partners spanning 12 countries. These partners have come together with a shared mission: to identify T1D at its pre-clinical stage in children in the general population. The project is funded through the Horizon Europe program and is set to run over five years.

EDENT1FI website

Press release

European pre-T1D Registry

European pre-T1D Registry is a network of investigators who register children and adults diagnosed with early-stage type 1 diabetes to inform about monitoring, trials, and treatment to delay or prevent disease progression. European pre-T1D Registry is operated by Helmholtz Munich under the umbrella of GPPAD & INNODIA.

pre-T1D Registry website

pre-T1D Registry dashboard

K1DS ARE HEROES

The K1DS ARE HEROES campaign spots type 1 diabetes heroes around the world! The campaign aims to raise awareness for type 1 diabetes, early detection and prevention of type 1 diabetes. The campaign is run by GPPAD together with the Institute of Diabetes Research (IDF) at Helmholtz Munich.

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

First results of the Primary Oral Insulin Trial (POInT) mark an important step towards the prevention of type 1 diabetes, pointing future efforts to personalized strategies. The group led by researchers from Helmholtz Munich and the Technical…

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease. However, children born to mothers with T1D are less likely to develop the disease than those whose fathers or siblings have T1D. A new study…

Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, is awarded with this year’s Hamm International Prize. She is being honored for her research to understand the pathogenesis of type 1 diabetes and efforts…

Vierte Helmholtz Munich Expert Hour im Deutschen Bundestag

Science and politics came together once again at the German Bundestag: For the fourth time, Helmholtz Munich hosted the Helmholtz Munich Expert Hour on September 10, 2025. This dialogue format gives political decision-makers the opportunity to learn…

kind-spielt-institut-fotoshooting-nozy-andreas pfohl-220727_0587 mit Logofr1da

The Helmholtz Munich Institute for Diabetes Research has been awarded a grant of over 1 Mio. Dollar from Breakthrough T1D, a global organization focused on type 1 diabetes research and advocacy, to intensify the longstanding Fr1da-Cohort-Study. The…

Warncke, K., Weiss, A., Achenbach, P., von dem Berge, T., Berner, R., Casteels, K., Groele, L., Hatzikotoulas, K., Hommel, A., Kordonouri, O., Elding Larsson, H., Lundgren, M., Marcus, B. A., Snape, M. D., Szypowska, A., Todd, J. A., Bonifacio, E., Ziegler, A. G., & GPPAD and POInT Study Groups

Elevations in blood glucose before and after the appearance of islet autoantibodies in children.

Ziegler, A.-G. ; Kick, K. ; Bonifacio, E. ; Haupt, F. ; Hippich, M. ; Dunstheimer, D. ; Lang, M. ; Laub, O. ; ... ; Assfalg, R. ; Jolink, M. ; Winkler, C. ; Achenbach, P.

Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany.

Hippich, M. ; Beyerlein, A. ; Hagopian, W.A. ; Krischer, J.P. ; Vehik, K. ; Knoop, J. ; Winker, C. ; ... ; Ziegler, A.-G. ; The Teddy Study Group

Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families.

Anette G. Ziegler, MD; Marian Rewers, MD, PhD; Olli Simell, MD, PhD; Tuula Simell, MPH, PhD; Johanna Lempainen, MD, PhD; Andrea Steck, MD; Christiane Winkler, PhD; Jorma Ilonen, MD, PhD; Riitta Veijola, MD, PhD; Mikael Knip, MD, PhD; Ezio Bonifacio, PhD; George S. Eisenbarth, MD, PhD

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children.

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)

View profile

Prof. Dr. med. Peter Achenbach

Deputy Director, Lead Scientist Research Area: Study Center for Childhood Diabetes

View profile

Prof. Dr. oec. troph. Sandra Hummel

Lead Scientist Research Area: Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes

View profile

Dr. rer. biol. hum. Christiane Winkler

Lead Scientist Research Area: Early Diagnosis & Staging of Type 1 Diabetes, and Phenotyping

View profile

Dr. Raffael Ott

Lead Scientist Research Area: Computational Biology and Immune Response Trajectories of Type 1 Diabetes Development

View profile

Dr. rer. nat. Florian Haupt

Lead Scientist Research Area: Digital Networking for Type 1 Diabetes Research

View profile

Dr. Teresa Rodriguez-Calvo

Lead Scientist Research Group: Type 1 Diabetes Pathology

View profile

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)

+49 89 3187 2896

anettegabriele.zieglerspam prevention@helmholtz-munich.de

Heidemannstraße 1, 80939 München

View profile

Institute of Diabetes Research

On This Page

Research Areas

Early Diagnosis & Staging of Type 1 Diabetes, and Phenotyping

Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)

Diabetes Study Center - Studies for Prevention and Immunotherapy of Type 1 Diabetes

Digital Networking for Type 1 Diabetes Research

Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes

Computational Biology and Immune Response Trajectories of Type 1 Diabetes Development

Research Group: Type 1 Diabetes Pathology

Research Platforms

EDENT1FI

European pre-T1D Registry

Campaigns

K1DS ARE HEROES

News

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

New Milestone Towards Personalized Prevention of Type 1 Diabetes

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Anette-Gabriele Ziegler Receives Hamm International Prize for Diabetes Research

Helmholtz Munich Expert Hour at the German Bundestag: The Future of Preventive Medicine

Fr1da-Cohort-Study Receives Grant to Facilitate the Integration of Early-Stage Type 1 Diabetes Screening Into Standard Care

Currently Recruiting

Freder1k study

AVAnT1A study

Fr1da study

Highlight publications

Networks & Affiliations

DZD

INNODIA

TrialNet

GPPAD

Fr1da plex

Teddy consortium

nPOD

diabinfo

pre-T1D registry

EDENT1FI

Team

Contact